H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation

14 January 2022: Database Analysis

Zongkuo Li ^12AE , Menglong Hu ^12A , Jinhuan Qiu ^12C , Junkai Feng ^12C , Ruizhen Zhang ^1C , Huifang Wu ^1D , Guiming Hu ^1D , Jingli Ren ^1G*

DOI: 10.12659/MSM.933447

Med Sci Monit 2022; 28:e933447

Table 3 Association between H2AFZ expression and clinicopathological characteristics in patients with LUAD in our cohort.

Characteristics	H2AFZ expression		Total	p Value
Characteristics	Low (n=220)	High (n=219)	Total	p Value
Age
	29	51	80	0.865
≥65	10	19	29	0.865
Gender
Male	14	40	54
Female	25	30	55
Pathological stage
I	25	36	61
II	5	23	28
III	8	6	14
IV	1	5	6
T classification
T1	23	45	68	0.801
T2	10	18	28
T3	5	5	10
T4	1	2	3
N classification
N0	23	41	64	0.679
N1	4	11	15
N2	12	18	30
N3
Bold values indicate